NCT00003250View on ClinicalTrials.gov

Fenretinide in Treating Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 31, 1998

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

fenretinide

Trial Locations (1)

48201

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00003250 - Fenretinide in Treating Patients With Solid Tumors | Biotech Hunter | Biotech Hunter